Information on research, events, activities, and news from the T1D community across Canada.
Dr. Rémi Rabasa-Lhoret, a JDRF-funded endocrinologist at the Institut de recherches cliniques de Montréal best known for his work on the...Read More
Dr. Esteban N. Gurzov, a talented young scientist from Brussels, Belgium, was recently named the first recipient of JDRF’s Dr. Robert Goldstein Award.
From Walk participant to trial participant to T1D advocate, here is Ash Hunkin's story.
We are pleased to announce Dr. Sarah Linklater has been appointed as Chief Scientific Officer (CSO).
Recently, a team of researchers in the United States developed a test to identify individuals of African descent who are more likely to get the disease.
Does Vitamin D play a role in developing type 1 diabetes (T1D)?
Since 2016, JDRF and Sernova Corp., a clinical-stage regenerative medicine company, have been collaborating on innovative technology to treat hypoglycaemia (low sugar) unawareness in patients with severe T1D.
Currently, JDRF-funded researcher, Dr. Jan Dutz, and his team at the University of British Columbia are investigating whether the administration of an antibody called ustekinumab among adults and children newly diagnosed with T1D can protect insulin-producing beta cells.
Administering insulin on a daily basis can be a tedious task, particularly among individuals newly diagnosed with type 1 diabetes (T1D). To mitigate this, researchers are currently experimenting with islet (insulin-producing cells) transplantation as a promising therapy that eliminates the need for ...
#AccessForAll: We're demanding affordable and accessible coverage for everyone living with type 1 diabetes
JDRF is excited to be launching our new Access for All campaign this week to urge provincial and territorial governments, insurers and employers to help make life-changing technologies affordable and accessible for Canadians with type 1 diabetes.